AmpliMed Corporation

AmpliMed Corporation Focuses on the Development of Small Molecule Cancer Drugs. Its products include Amplimexon, a small molecule drug that causes cancer cells to stop dividing and eventually die. The company’s products can be used to treat pancreatic cancer, lung cancer, malignant melanoma, ovarian cancer, and multiple myeloma.